Deep sequencing reveals microRNAs predictive of antiangiogenic drug response.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  JCI Insight

• Publication date

  2016-07-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/jci.insight.86051PMID 27699216PMCID PMC5033860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis

  2015cited by this paper
• miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma.

  2015cited by this paper
• MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma

  2015cited by this paper
• microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo.

  2015cited by this paper
• TGFβ Triggers miR-143/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization.

  2015cited by this paper
• A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma

  2015cited by this paper
• MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization

  2015cited by this paper
• Renal carcinoma pharmacogenomics and predictors of response: Steps toward treatment individualization.

  2015cited by this paper
• Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression

  2015cited by this paper
• The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma

  2015cited by this paper
• Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.

  2015cited by this paper
• The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer

  2015cited by this paper
• The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment.

  2015cited by this paper
• The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

  2014cited by this paper
• Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients

  2014cited by this paper
• HTSeq—a Python framework to work with high-throughput sequencing data

  2014cited by this paper
• Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection

  2014cited by this paper
• Differential expression of microRNA501-5p affects the aggressiveness of clear cell renal carcinoma

  2014cited by this paper
• Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma

  2014cited by this paper
• miR-133a mediates the hypoxia-induced apoptosis by inhibiting TAGLN2 expression in cardiac myocytes

  2014cited by this paper
• Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma

  2014cited by this paper
• The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling

  2014cited by this paper
• Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers

  2014cited by this paper
• MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases

  2014cited by this paper
• Identification of potential biomarkers for clear cell renal cell carcinoma based on microRNA-mRNA pathway relationships.

  2014cited by this paper
• Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

  2014cited by this paper
• miRBase: annotating high confidence microRNAs using deep sequencing data

  2013cited by this paper
• miR-1 and miR-206 target different genes to have opposing roles during angiogenesis in zebrafish embryos

  2013cited by this paper
• Development and validation of a microRNA‐based diagnostic assay for classification of renal cell carcinomas

  2013cited by this paper
• Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy.

  2013cited by this paper
• COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA

  2013cited by this paper
• Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.

  2013cited by this paper
• Count-based differential expression analysis of RNA sequencing data using R and Bioconductor

  2013cited by this paper
• A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistance.

  2013cited by this paper
• MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells.

  2013cited by this paper
• Constitutional genetic variants as predictors of antiangiogenic therapy outcome in renal cell carcinoma.

  2012cited by this paper
• MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer

  2012cited by this paper
• miR221/222 in cancer: their role in tumor progression and response to therapy.

  2012cited by this paper
• Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis

  2012cited by this paper
• High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries

  2012cited by this paper
• miR-221 is required for endothelial tip cell behaviors during vascular development.

  2012cited by this paper
• Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma

  2011cited by this paper
• Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study.

  2011cited by this paper
• MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

  2010cited by this paper
• Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.

  2010cited by this paper
• MicroRNAs as novel regulators of angiogenesis.

  2009cited by this paper
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• Searching for SNPs with cloud computing

  2009cited by this paper
• Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

  2009cited by this paper
• Role of microRNAs in vascular diseases, inflammation, and angiogenesis.

  2008cited by this paper
• Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.

  2008cited by this paper
• Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

  2007cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995influential reference

• Regulatory roles of non-coding and exosomal RNAs in colorectal cancer: spotlight on angiogenesis

  2025cites this paper
• Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins

  2025cites this paper
• MicroRNA‐1307‐3p contributes to breast cancer progression through PRM2

  2024cites this paper
• Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients

  2024cites this paper
• The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis

  2023influential citation
• Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer

  2023cites this paper
• miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review

  2022cites this paper
• Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade

  2022cites this paper
• Epigenetics in advanced renal cell carcinoma: potential new targets.

  2022cites this paper
• MiRNAs in renal cell carcinoma

  2022cites this paper
• A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma

  2022cites this paper
• Liquid biopsy in kidney tumor

  2022cites this paper
• MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma

  2021cites this paper
• Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.

  2021cites this paper
• MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma

  2021cites this paper
• Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Association between Genetic Polymorphisms of miR-1307, miR-1269, miR-3117 and Breast Cancer Risk in a Sample of South East Iranian Women

  2021cites this paper
• MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets

  2020cites this paper
• MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer.

  2020cites this paper
• miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro

  2020cites this paper
• Genomics functional analysis and drug screening of SARS-CoV-2

  2020cites this paper
• Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma

  2020cites this paper
• Antiangiogenic therapies for pheochromocytoma and paraganglioma.

  2020cites this paper
• Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma

  2020cites this paper
• Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs

  2020cites this paper
• Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical Biomarkers

  2020cites this paper
• [Pilot Study on MicroRNAs as Biomarkers of Response to Sunitinib Treatment in Patients with Metastatic Renall Cell Carcinoma].

  2019cites this paper
• A study of the role of microRNAs in gastric cancer : the effect of miR-140-5p dysregulation in the expression of MDM2 in p53-dependent gastric cancer subtypes

  2019cites this paper
• Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis

  2019cites this paper
• miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.

  2019cites this paper
• Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study

  2019cites this paper
• MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma

  2019cites this paper
• Noncoding RNAs as Predictive Biomarkers of Therapeutic Response to Tyrosine Kinase Inhibitors in Metastatic Cancer

  2019cites this paper
• Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes

  2019cites this paper
• Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma

  2019cites this paper
• Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature

  2018cites this paper
• MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma

  2018influential citation
• TKIs in Renal Cell Carcinoma

  2018cites this paper
• Predictive Biomarkers and Targeted Therapies in Genitourinary Cancers

  2018cites this paper
• miR-1307-3p suppresses the chondrogenic differentiation of human adipose-derived stem cells by targeting BMPR2

  2018cites this paper
• Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases.

  2018cites this paper
• Epigenetics in renal cell cancer: mechanisms and clinical applications

  2018cites this paper
• Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor Response.

  2018cites this paper
• Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma

  2017cites this paper
• MicroRNAs as biomarkers in chronic kidney disease

  2017cites this paper
• miRNAs: micro-managers of anticancer combination therapies

  2017cites this paper
• microRNAs Make the Call in Cancer Personalized Medicine

  2017influential citation